Rabeprazole and Camizestrant: Interaction Details

Brand names
Rabeprazole
AciphexAcipHex Sprinkles
Dr. Brian Staiger, PharmD, BCPS

Medically reviewed by ⁠

Also reviewed by the HelloPharmacist Editorial Team Updated AI-assisted Details about this page
Share

Share this interaction

Rabeprazole

Brand names
  • Aciphex
  • AcipHex Sprinkles

Camizestrant

We don't have a drug information page for Camizestrant yet. Have a question about Camizestrant? Ask a pharmacist, free →

What Happens When You Take Rabeprazole With Camizestrant

What can happen when they are taken together (rated Major)

Increased exposure and an increased risk of CYP2C19 substrate-related adverse reactions

Interaction Deep Dive

A note from Dr. Brian Staiger If you’re a patient, this deep dive may be too technical, or bore you (or both). Read the plain-language explanation →

Camizestrant is a strong CYP2C19 , so it should not be used together with a CYP2C19 substrate while camizestrant is being taken or for at least 2 weeks after the final camizestrant dose. The may raise exposure to the substrate and thereby increase the risk of substrate-related adverse reactions.

A drug interaction study predicts that giving camizestrant with warfarin (a sensitive CYP2C19 substrate) would raise warfarin by 1.1-fold and by 13-fold. Likewise, administration with camizestrant is predicted to raise the Cmax of siponimod (a moderately sensitive CYP2C19 substrate) by 1.1-fold and its AUC by 5.3-fold.1

The Rabeprazole and Camizestrant Interaction, Explained

Camizestrant can block , one of the liver enzymes that helps clear rabeprazole. With both medicines on board, more rabeprazole may stay in your body than usual. That could raise the chance of rabeprazole side effects, such as headache, diarrhea, or stomach upset. This effect can last for at least 2 weeks after your last camizestrant dose.

The database rates this as a major interaction, so it should be taken seriously. Please don't stop or change either medicine on your own. Talk with your pharmacist or doctor, who can review whether you need both and how best to manage your care.

Mechanism: Camizestrant is a strong . Rabeprazole is a CYP2C19 (alongside substantial non-enzymatic reduction and involvement), so exposure is expected to increase, with a greater risk of substrate-related adverse effects.

  • Magnitude: Not quantified for rabeprazole. For other CYP2C19 substrates, predicted increases were 13-fold (warfarin) and 5.3-fold (siponimod), with increases of about 1.1-fold.
  • Onset: Unspecified. is expected to persist at least 2 weeks after the last camizestrant dose.
  • Evidence: Probable (labeling and predicted data).
  • Management: Avoid during treatment and for at least 2 weeks after the last dose. If coadministration is unavoidable, individualize the rabeprazole dose and monitor for adverse effects.

See the 1 reference behind this explanation ↓

From the HelloPharmacist Pharmacy Team

AI-assisted: written with AI from this pair’s record in our interaction database, and reviewed by the HelloPharmacist pharmacy team. Written .

How we build these pages · How we use AI · Our editorial policy

Why Rabeprazole and Camizestrant Interact

The likely mechanism

of -substrate by camizestrant

How Drug Interactions Work Six short figures, about a minute: how one drug can raise or lower another’s level, or add to or cancel its effect. See how it works 

How to Manage the Rabeprazole and Camizestrant Interaction

The documented advice is to avoid using these two medicines together while on camizestrant and for at least 2 weeks after the last camizestrant dose.

  • Keep taking your medicines as prescribed until your care team tells you otherwise.
  • Tell your pharmacist and prescriber that you take both rabeprazole and camizestrant.
  • Your team may review whether another approach is suitable, or may adjust your dose and monitor you more closely.
  • Report any new or worsening side effects, such as headache, diarrhea, or stomach upset.

Management is individual — confirm any change with your pharmacist or prescriber.

Questions for Your Pharmacist

  • Does my dose of Rabeprazole or Camizestrant need adjusting while I take them together?
  • What symptoms should prompt me to call you or my prescriber right away?
  • Does the timing of my doses matter for this combination?
  • Is there another option that avoids this interaction?

Literature Reports

1 report from the published literature. Each one is headed by the title of the published study it comes from.

What these reports are. Short summaries of published evidence on this combination: clinical studies, case reports and, at times, the FDA prescribing information for one of the drugs. They support this interaction, but it does not rest on them alone. It can also rest on prescribing information not summarized here, or on what is expected from how these two drugs, and others in their drug classes, are known to work.

  1. Report 1 · Study title

    Prescribing information: ETCAMAH oral tablet, camizestrant oral tablet

    In a drug interaction study, of camizestrant and omeprazole (a sensitive ) is predicted to raise omeprazole by 3.3-fold and by 8.5-fold. Likewise, giving camizestrant together with lansoprazole (a moderately sensitive CYP2C19 substrate) is predicted to raise lansoprazole Cmax by 1.5-fold and AUC by 5.7-fold.1

Rabeprazole and Camizestrant: Common Questions

How serious is the Rabeprazole and Camizestrant interaction?

It is rated major. Potentially serious — often needs a change or close monitoring.

How is the Rabeprazole and Camizestrant interaction managed?

The documented advice is to avoid using these two medicines together while on camizestrant and for at least 2 weeks after the last camizestrant dose. Keep taking your medicines as prescribed until your care team tells you otherwise. Tell your pharmacist and prescriber that you take both rabeprazole and camizestrant. Your team may review whether another approach is suitable, or may adjust your dose… Management is individual — always follow your own care team's guidance.

How quickly could this interaction happen?

The documented onset is "unspecified". The timing of this interaction is not well characterized.

How strong is the evidence for this interaction?

The evidence is graded "probable". Good supporting evidence, though not definitively proven.

Ask About the Rabeprazole and Camizestrant Interaction

Ask in your own words about taking Rabeprazole and Camizestrant together. The answer comes from this page’s interaction record and both drugs’ own information.

This box answers questions about this one combination only. For anything else about either drug, open its drug information page or ask a pharmacist.

Try:

AI answers from this page’s record and both drugs’ information, never the open internet. AI can make mistakes, so always check with your doctor or pharmacist.

References (1)

  1. Product Information: ETCAMAH® oral tablet, camizestrant oral tablet. AstraZeneca Pharmaceuticals LP, Wilmington, DE, 2026. DailyMed
Was this write-up helpful?

Other Serious Interactions of Rabeprazole and Camizestrant

Also serious with Rabeprazole

These Medications Also Interact With Supplements

Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:

With Rabeprazole

Check everything you take with our drug–supplement interaction checker.

Still Have Questions About This Combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

About This Library

Built in-house, documented one interaction at a time. Our interaction database is not a complete list of every known interaction: a combination that isn't listed here hasn't been documented by us yet, which never means it's safe. Checking everything you take at once? Ask your pharmacist to review your full medication list. How we build and review it →

What Each Rating Means

Severity Levels

  • Contraindicated These should generally not be used together.
  • Major Potentially serious — often needs a change or close monitoring. This interaction.
  • Moderate Can be significant — usually manageable with monitoring.
  • Minor Usually limited clinical impact.

Evidence Grades

  • EstablishedWell documented — supported by controlled studies or strong clinical data.
  • ProbableGood supporting evidence, though not definitively proven. This interaction.
  • SuspectedSome evidence suggests this interaction, but it is not well established.
  • PossibleLimited or conflicting evidence; the interaction may occur.
  • TheoreticalExpected from how the drugs work, or from studies of similar drugs; this exact pair has little direct study.

How Soon It Shows

  • RapidEffects can appear quickly, often within about 24 hours of combining the drugs.
  • DelayedEffects tend to build up gradually over days to weeks.
  • UnspecifiedThe timing of this interaction is not well characterized. This interaction.

Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.

Back to the answer
This information is for education, not a substitute for professional medical advice. Do not start, stop, or change any medication without talking to your pharmacist or prescriber.